Symbol: |
LRFN4
|
Description: |
leucine rich repeat and fibronectin type III domain containing 4 [Source:HGNC Symbol;Acc:28456]
|
Location: |
Chr11:66624118-66627946[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:187
Gene |
Compound |
Gen_sig |
Exp_pattern |
LRFN4 |
NSC 105348 |
0.011 |
Up |
LRFN4 |
Musennin |
0.018 |
Up |
LRFN4 |
NSC 113491 |
0.001 |
Down |
LRFN4 |
NSC 11865 |
0.011 |
Down |
LRFN4 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.001 |
Down |
LRFN4 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.032 |
Down |
LRFN4 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.001 |
Down |
LRFN4 |
AT 116, benzylamine salt |
0.043 |
Up |
LRFN4 |
NSC 166382 |
0.025 |
Down |
LRFN4 |
NSC 16857 |
0.045 |
Down |
LRFN4 |
Bromocriptine methanesulfonate |
0.038 |
Down |
LRFN4 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.001 |
Down |
LRFN4 |
Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- |
0.024 |
Down |
LRFN4 |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.001 |
Down |
LRFN4 |
NSC 227265 |
0.016 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:2
SNP |
Gene |
SNP_location |
SNP_allele |
rs35390863 |
LRFN4 |
Chr11:66627739 |
-/A |
rs113659922 |
LRFN4 |
Chr11:66627765 |
C/G |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
|